The Chicken Hypersensitivity Site 4 Core Insulator Blocks Promoter Interference in Lentiviral Vectors

Abstract

Lentiviral vectors, including double internal promoters, can be used to express two transgenes in a single vector construct; however, transcriptional activities from double internal promoters are often inhibited by promoter interference. To determine whether the chicken hypersensitivity site 4 insulator (cHS4) could block promoter interference, lentiviral vectors including an MSCV-U3 promoter (Mp) and an EF1α promoter (Ep) were generated, and transgene expression was evaluated among transduced cells. In the Ep-Mp configuration, transcriptional activity from Mp was much lower, while Mp-Ep had similar transcription levels from both promoters. The cHS4 core insulator increased expression levels from Mp in HeLa cells, hematopoietic cell lines, and mouse peripheral blood cells following hematopoietic stem cell transplantation transduced with the Mp-Ep configured vector. This blocking function was mainly mediated by barrier activity regions in the insulator but not by CCCTC-binding factor (CTCF) binding sites. Cytosine-phosphate-guanine (CpG) methylation did not contribute to this barrier activity. In summary, combining the cHS4 insulator in double promoter vectors can improve transgene expression levels in various cell lines and mouse hematopoietic repopulating cells. These findings are useful for developing hematopoietic stem cell gene therapy.

Uchida and colleagues demonstrate that the chicken hypersensitivity site 4 insulator (cHS4) is able to block promoter interference in lentiviral vectors containing double internal promoters. The cHS4 core insulator increased expression levels in HeLa cells, hematopoietic cell lines, and mouse peripheral blood cells following transplantation with lentivirus-transduced hematopoietic stem cells.

Get full access to this article

View all access options for this article.

References

Aker

, Tubb

, Groth

A.C.

et al. 2007. Extended core sequences from the cHS4 insulator are necessary for protecting retroviral vectors from silencing position effects. Hum. Gene Ther., 18:333–343.

Arumugam

P.I.

, Scholes

, Perelman

et al. 2007. Improved human beta-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator element. Mol. Ther., 15:1863–1871.

Barkess

, West

A.G.

2012. Chromatin insulator elements: establishing barriers to set heterochromatin boundaries. Epigenomics, 4:67–80.

Ben-Dor

, Itsykson

, Goldenberg

et al. 2006. Lentiviral vectors harboring a dual-gene system allow high and homogeneous transgene expression in selected polyclonal human embryonic stem cells. Mol. Ther., 14:255–267.

Burgess-Beusse

, Farrell

, Gaszner

et al. 2002. The insulation of genes from external enhancers and silencing chromatin. Proc. Natl. Acad. Sci. U.S.A., 99,Suppl 4:16433–16437.

Cavazzana-Calvo

, Payen

, Negre

et al. 2010. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature, 467:318–322.

Curtin

J.A.

, Dane

A.P.

, Swanson

et al. 2008. Bidirectional promoter interference between two widely used internal heterologous promoters in a late-generation lentiviral construct. Gene Ther., 15:384–390.

de Felipe

, Martin

, Cortes

M.L.

et al. 1999. Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy. Gene Ther., 6:198–208.

Dupuy

F.P.

, Mouly

, Mesel-Lemoine

et al. 2005. Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters. J. Gene Med., 7:1158–1171.

10.

Emery

D.W.

, Yannaki

, Tubb

et al. 2000. A chromatin insulator protects retrovirus vectors from chromosomal position effects. Proc. Natl. Acad. Sci. U.S.A., 97:9150–9155.

11.

Ginn

S.L.

, Fleming

, Rowe

P.B.

et al. 2003. Promoter interference mediated by the U3 region in early-generation HIV-1-derived lentivirus vectors can influence detection of transgene expression in a cell-type and species-specific manner. Hum. Gene Ther., 14:1127–1137.

12.

Hacein-Bey-Abina

, Garrigue

, Wang

G.P.

et al. 2008. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest., 118:3132–3142.

13.

Hanawa

, Kelly

P.F.

, Nathwani

A.C.

et al. 2002. Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol Ther, 5:242–251.

14.

Ott

M.G.

, Schmidt

, Schwarzwaelder

et al. 2006. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med, 12:401–409.

15.

Papapetrou

E.P.

, Lee

, Malani

et al. 2011. Genomic safe harbors permit high beta-globin transgene expression in thalassemia induced pluripotent stem cells. Nat. Biotechnol., 29:73–78.

16.

Proudfoot

N.J.

1986. Transcriptional interference and termination between duplicated alpha-globin gene constructs suggests a novel mechanism for gene regulation. Nature, 322:562–565.

17.

Robert-Richard

, Richard

, Malik

et al. 2007. Murine retroviral but not human cellular promoters induce in vivo erythroid-specific deregulation that can be partially prevented by insulators. Mol. Ther., 15:173–182.

18.

Ryu

B.Y.

, Evans-Galea

M.V.

, Gray

J.T.

et al. 2008. An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation. Blood, 111:1866–1875.

19.

Steinwaerder

D.S.

, Lieber

2000. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo. Gene Ther., 7:556–567.

20.

Uchida

, Washington

K.N.

, Hayakawa

et al. 2009. Development of a human immunodeficiency virus type 1-based lentiviral vector that allows efficient transduction of both human and rhesus blood cells. J. Virol., 83:9854–9862.

21.

Uchida

, Washington

K.N.

, Lap

C.J.

et al. 2011. Chicken HS4 insulators have minimal barrier function among progeny of human hematopoietic cells transduced with an HIV1-based lentiviral vector. Mol. Ther., 19:133–139.

22.

Villemure

J.F.

, Savard

, Belmaaza

2001. Promoter suppression in cultured mammalian cells can be blocked by the chicken beta-globin chromatin insulator 5'HS4 and matrix/scaffold attachment regions. J Mol. Biol., 312:963–974.

23.

Yahata

, Maeshima

, Sone

et al. 2007. cHS4 insulator-mediated alleviation of promoter interference during cell-based expression of tandemly associated transgenes. J. Mol. Biol., 374:580–590.

24.

, Zhan

, D'Costa

et al. 2003. Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells. Mol. Ther., 7:827–838.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.05 MB

0.07 MB

0.04 MB